Change of Adviser

Sinclair IS Pharma plc (the "Company")

Change of Nominated Adviser and Broker

19 December 2012, Sinclair IS Pharma plc (AIM:SPH.L) , the international specialty pharma company, announces that it has appointed Peel Hunt LLP as its Nominated Adviser and Broker with immediate effect. Jefferies International Limited and Peel Hunt LLP will be acting as joint Financial Advisers to the Company.

For further information please contact:

Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner

Alan Olby

Robert Taylor

Peel Hunt LLP Tel: +44 (0) 20 7418 8900

James Steel

Vijay Barathan

Notes to Editors:

About Sinclair IS Pharma plc - www.sinclairispharma.com 

Sinclair IS Pharma is an international specialty pharmaceutical company focused on treatments in dermatology, wound care, oncology support and critical care through advanced surface technology and innovative delivery systems. The Company has a growing sales and marketing operation with a direct sales presence in the top five European markets and an extensive marketing partner network across selected developed and emerging markets.

"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward ‐ looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward ‐ looking statements due to a variety of   factors